Related Experiment Video
Updated: Oct 20, 2025
Methylated DNA Immunoprecipitation
Published on: January 2, 2009
The roles of epigenetics in cancer progression and metastasis
Jocelyn F Chen1, Qin Yan1,2,3,4
1Department of Pathology, Yale School of Medicine, New Haven, CT, U.S.A.
Abstract:
Cancer metastasis remains a major clinical challenge for cancer treatment. It is therefore crucial to understand how cancer cells establish and maintain their metastatic traits. However, metastasis-specific genetic mutations have not been identified in most exome or genome sequencing studies. Emerging evidence suggests that key steps of metastasis are controlled by reversible epigenetic mechanisms, which can be targeted to prevent and treat the metastatic disease. A variety of epigenetic mechanisms were identified to regulate metastasis, including the well-studied DNA methylation and histone modifications. In the past few years, large scale chromatin structure alterations including reprogramming of the enhancers and chromatin accessibility to the transcription factors were shown to be potential driving force of cancer metastasis. To dissect the molecular mechanisms and functional output of these epigenetic changes, it is critical to use advanced techniques and alternative animal models for interdisciplinary and translational research on this topic. Here we summarize our current understanding of epigenetic aberrations in cancer progression and metastasis, and their implications in developing new effective metastasis-specific therapies.
Insights
Epigenetic alterations, not just genetic mutations, drive cancer metastasis. Targeting these reversible epigenetic changes offers new therapeutic strategies for preventing and treating metastatic cancer.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer metastasis is a primary obstacle in effective cancer treatment.
- Genetic mutations alone do not fully explain metastasis; epigenetic factors are increasingly recognized.
- Reversible epigenetic mechanisms are crucial for cancer cells to acquire and maintain metastatic traits.
Purpose of the Study:
- To review current understanding of epigenetic aberrations in cancer progression and metastasis.
- To highlight the role of epigenetic mechanisms in driving metastatic traits.
- To discuss the therapeutic implications of targeting epigenetic changes for metastasis-specific treatments.
Main Methods:
- Review of existing literature on epigenetic regulation in cancer metastasis.
- Analysis of studies investigating DNA methylation, histone modifications, and chromatin structure.
- Consideration of advanced techniques and animal models for translational research.
Main Results:
- Epigenetic mechanisms, including DNA methylation and histone modifications, are key regulators of metastasis.
- Large-scale chromatin alterations, such as enhancer reprogramming and changes in chromatin accessibility, significantly drive cancer metastasis.
- These epigenetic changes are reversible and represent viable therapeutic targets.
Conclusions:
- Epigenetic aberrations play a critical role in cancer progression and metastasis.
- Targeting reversible epigenetic mechanisms holds significant promise for developing novel, effective metastasis-specific therapies.
- Interdisciplinary research using advanced techniques and models is essential for advancing this field.
More Related Videos
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
Related Concept Videos
01:37Epigenetic Regulation
X-chromosome...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:38Mitogens and the Cell Cycle
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...